TEST BANK@nm
Lippincott Illustrated Reviews: Pharmacology
@nm @nm @nm
by Karen Whalen 8th EDITION.
@nm @nm
ALL CHAPTERS INCLUDED…ALL ANSWERS INCLUDED.
, Pharmacology @nmIllustrated @nmReviews @nm8th @nmEdition @nmWhalen @nmTest
Bank @nmTABLE @nmOF @nmCONTENT
@nm
Chapter @nm1: @nmPharmacokinetics
Chapter @nm2: @nmDrug–Receptor @nmInteractions @nmand @nmPharmacodynamics
Chapter @nm3: @nmThe @nmAutonomic @nmNervous @nmSystem
Chapter @nm4: @nmCholinergic @nmAgonists
Chapter @nm5: @nmCholinergic @nmAntagonists
Chapter @nm6: @nmAdrenergic @nmAgonists
Chapter @nm7: @nmAdrenergic @nmAntagonists
Chapter @nm8: @nmDrugs @nmfor @nmNeurodegenerative @nmDiseases
Chapter @nm9: @nmAnxiolytic @nmand @nmHypnotic @nmDrugs
Chapter @nm10: @nmAntidepressants
Chapter @nm11: @nmAntipsychotic @nmDrugs
Chapter @nm12: @nmDrugs @nmfor @nmEpilepsy
Chapter @nm13: @nmAnesthetics
Chapter @nm14: @nmOpioids
Chapter @nm15: @nmDrugs @nmof @nmAbuse
Chapter @nm16: @nmCNS @nmStimulants
Chapter @nm17: @nmAntihypertensives
Chapter @nm18: @nmDiuretics
Chapter @nm19: @nmHeart @nmFailure
Chapter @nm20: @nmAntiarrhythmics
Chapter @nm21: @nmAntianginal @nmDrugs
Chapter @nm22: @nmAnticoagulants @nmand @nmAntiplatelet @nmAgents
Chapter @nm23: @nmDrugs @nmfor @nmHyperlipidemia
Chapter @nm24: @nmPituitary @nmand @nmThyroid
Chapter @nm25: @nmDrugs @nmfor @nmDiabetes
Chapter @nm26: @nmEstrogens @nmand @nmAndrogens
Chapter @nm27: @nmAdrenal @nmHormones
Chapter @nm28: @nmDrugs @nmfor @nmObesity
Chapter @nm29: @nmDrugs @nmfor @nmDisorders @nmof @nmthe @nmRespiratory @nmSystem
Chapter @nm30: @nmAntihistamines
Chapter @nm31: @nmGastrointestinal @nmand @nmAntiemetic @nmDrugs
Chapter @nm32: @nmDrugs @nmfor @nmUrologic @nmDisorders
Chapter @nm33: @nmDrugs @nmfor @nmAnemia
Chapter @nm34: @nmDrugs @nmfor @nmDermatologic @nmDisorders
Chapter @nm35: @nmDrugs @nmfor @nmBone @nmDisorders
Chapter @nm36: @nmAnti-inflammatory, @nmAntipyretic, @nmand @nmAnalgesic @nmAgents
Chapter @nm37: @nmPrinciples @nmof @nmAntimicrobial @nmTherapy
Chapter @nm38: @nmCell @nmWall @nmInhibitors
Chapter @nm39: @nmProtein @nmSynthesis @nmInhibitors
Chapter @nm40: @nmQuinolones, @nmFolic @nmAcid @nm Antagonists, @nmand @nmUrinary @nmTract @nmAntiseptics
Chapter @nm41: @nmAntimycobacterial @nmDrugs
Chapter @nm42: @nmAntifungal @nmDrugs
Chapter @nm43: @nmAntiprotozoal @nmDrugs
Chapter @nm44: @nmAnthelmintic @nmDrugs
Chapter @nm45: @nmAntiviral @nmDrugs
Chapter @nm46: @nmAnticancer @nmDrugs
Chapter @nm47: @nmImmunosuppressants
Chapter @nm48: @nmClinical @nmToxicology
, Page @nm1 @nmof @nm507
Pharmacology @nmIllustrated @nmReviews @nm8th @nmEdition @nmWhalen @nmTest
Chapter @nm1:
@nmPharmacokinetics
MULTIPLE @nmCHOICE
1. Which drugs will go through a pharmaceutic phase after it is administered?
a. Intramuscular cephalosporins
b. Intravenous vasopressors
c. Oral analgesics
d. Subcutaneous antiglycemics
ANS: C
When drugs are administered parenterally, there is no pharmaceutic phase, which occurs when a
drug becomes a solution that can cross the biologic membrane.
DIF: COGNITIVE LEVEL: Understanding (Comprehension) REF: dm 3
TOP: NURSING PROCESS: Assessment
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
2. The nurse is preparing to administer an oral medication and wants to ensure a rapid drug
action. Which form of the medication will the nurse administer?
a. Capsule
b. Enteric-coated pill
c. Liquid suspension
d. Tablet
ANS: C
Liquid drugs are already in solution, which is the form necessary for absorption in the GI tract.
The other forms must disintegrate into small particles and then dissolve before being
absorbed.
DIF: COGNITIVE LEVEL: Understanding (Comprehension) REF: dm 3
TOP: NURSING PROCESS: Nursing Intervention
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
, 3. The @nmnurse @nmis @nmteaching @nma @nmpatient @nmwho @nmwill @nmbe @nmdischarged @nmhome @nmwith @nma
prescription @nmfor @nman @nmenteric- @nmcoated @nmtablet. @nmWhich @nmstatement @nmby @nmthe @nmpatient
@nm
@nm indicates @nmunderstanding @nmof @nmthe @nmteaching?
a. I@nmmay@nmcrush @nmthe @nmtablet @nm and @nmput @nmit @nmin @nmapplesauce @nmto @nmimprove @nmabsorption.
b. I@nmshould @nmconsume @nmacidic @nm foods @nmto @nmenhance @nmabsorption @nmof @nmthis @nmmedication.
c. I@nmshould @nmexpect @nm a @nmdelay @nmin @nmonset @nmof @nmthe @nmdrugs @nmeffects @nmafter @nmtaking @nmthe
@nmtablet.
d. I@nmshould @nmtake @nmthis @nmmedication @nmwith @nmhigh-fat @nmfoods @nmto
@nm improve @nmits @nmaction. @nmANS: @nmC
Enteric-coated @nmtablets @nmresist @nmdisintegration @nmin @nmthe @nmacidic @nmenvironment @nmof @nmthe
@nm stomach @nmand @nmdisintegrate @nmwhen @nmthey @nmreach @nmthe @nmsmall @nmintestine. @nmThere @nmis
@nm usually @nmsome @nmdelay @nmin @nmonset @nmof @nmactions @nmafter @nmtaking @nmthese @nmmedications.
@nm Enteric-coated @nmtablets @nmshould @nmnot @nmbe @nmcrushed @nmor @nmchewed, @nmwhich @nmwould @nmalter
@nm the @nmtime @nmand @nmlocation @nmof @nmabsorption. @nmAcidic @nmfoods @nmwill @nmnot @nmenhance @nmthe
@nm absorption @nmof @nmthe @nmmedication. @nmThe @nmpatient @nmshould @nmnot @nmto @nmeat @nmhigh-fat @nmfood
@nm before @nmingesting @nman @nmenteric-coated @nmtablet, @nmbecause @nmhigh-fat @nmfoods @nmdecrease
@nm the @nmabsorption @nmrate.
DIF: @nmCOGNITIVE @nmLEVEL: @nmApplying @nm(Application) @nmREF:
dm @nm3 @nmTOP: @nmNURSING @nmPROCESS: @nmNursing
@nm
@nm Intervention
MSC: @nmNCLEX: @nmPhysiological @nmIntegrity: @nmPharmacological @nmand @nmParenteral @nmTherapies
4. A @nmpatient @nmwho @nmis @nmnewly @nmdiagnosed @nmwith @nmtype @nm1 @nmdiabetes @nmmellitus @nmasks
@nm why @nminsulin @nmmust @nmbe @nmgiven @nmby@nmsubcutaneous @nminjection @nminstead @nmof @nmby@nmmouth.
@nm The @nmnurse @nmwill @nmexplain @nmthat @nmthis @nmis @nmbecause
a. absorption @nmis @nmdiminished @nmby @nmthe @nmfirst-pass @nmeffects @nmin @nmthe @nmliver.
b. absorption @nmis @nmfaster @nmwhen @nminsulin @nmis @nmgiven @nmsubcutaneously.
c. digestive @nmenzymes @nmin @nmthe @nmgastrointestinal @nmtract @nmprevent @nmabsorption.
d. the @nmoral @nmform @nmis @nmless@nmpredictable @nmwith @nmmore
adverse @nmeffects. @nmANS: @nmC
@nm
Insulin, @nmgrowth @nmhormones, @nmand @nmother @nmprotein-based @nmdrugs @nmare @nmdestroyed @nmin @nmthe
small @nmintestine @nmby @nmdigestive @nmenzymes @nmand @nmmust @nmbe @nmgiven @nmparenterally.
@nm
@nm Because @nminsulin @nmis @nmdestroyed @nmby @nmdigestive @nmenzymes, @nmit @nmwould @nmnot @nmmake @nmit
@nm to @nmthe @nmliver @nmfor @nmmetabolism @nmwith @nma @nmfirst-pass @nmeffect. @nmSubcutaneous @nmtissue @nmhas
@nm fewer @nmblood @nmvessels, @nmso @nmabsorption @nmis @nmslower @nmin @nmsuch @nmtissue. @nmInsulin @nmis
@nm given @nmsubcutaneously @nmbecause @nmit @nmis @nmdesirable @nmto @nmhave @nmit @nmabsorb @nmslowly.
DIF: @nmCOGNITIVE @nmLEVEL: @nmUnderstanding @nm(Comprehension)
REF: @nmdm @nm3 @nmTOP: @nmNURSING @nmPROCESS: @nmNursing
@nm
Lippincott Illustrated Reviews: Pharmacology
@nm @nm @nm
by Karen Whalen 8th EDITION.
@nm @nm
ALL CHAPTERS INCLUDED…ALL ANSWERS INCLUDED.
, Pharmacology @nmIllustrated @nmReviews @nm8th @nmEdition @nmWhalen @nmTest
Bank @nmTABLE @nmOF @nmCONTENT
@nm
Chapter @nm1: @nmPharmacokinetics
Chapter @nm2: @nmDrug–Receptor @nmInteractions @nmand @nmPharmacodynamics
Chapter @nm3: @nmThe @nmAutonomic @nmNervous @nmSystem
Chapter @nm4: @nmCholinergic @nmAgonists
Chapter @nm5: @nmCholinergic @nmAntagonists
Chapter @nm6: @nmAdrenergic @nmAgonists
Chapter @nm7: @nmAdrenergic @nmAntagonists
Chapter @nm8: @nmDrugs @nmfor @nmNeurodegenerative @nmDiseases
Chapter @nm9: @nmAnxiolytic @nmand @nmHypnotic @nmDrugs
Chapter @nm10: @nmAntidepressants
Chapter @nm11: @nmAntipsychotic @nmDrugs
Chapter @nm12: @nmDrugs @nmfor @nmEpilepsy
Chapter @nm13: @nmAnesthetics
Chapter @nm14: @nmOpioids
Chapter @nm15: @nmDrugs @nmof @nmAbuse
Chapter @nm16: @nmCNS @nmStimulants
Chapter @nm17: @nmAntihypertensives
Chapter @nm18: @nmDiuretics
Chapter @nm19: @nmHeart @nmFailure
Chapter @nm20: @nmAntiarrhythmics
Chapter @nm21: @nmAntianginal @nmDrugs
Chapter @nm22: @nmAnticoagulants @nmand @nmAntiplatelet @nmAgents
Chapter @nm23: @nmDrugs @nmfor @nmHyperlipidemia
Chapter @nm24: @nmPituitary @nmand @nmThyroid
Chapter @nm25: @nmDrugs @nmfor @nmDiabetes
Chapter @nm26: @nmEstrogens @nmand @nmAndrogens
Chapter @nm27: @nmAdrenal @nmHormones
Chapter @nm28: @nmDrugs @nmfor @nmObesity
Chapter @nm29: @nmDrugs @nmfor @nmDisorders @nmof @nmthe @nmRespiratory @nmSystem
Chapter @nm30: @nmAntihistamines
Chapter @nm31: @nmGastrointestinal @nmand @nmAntiemetic @nmDrugs
Chapter @nm32: @nmDrugs @nmfor @nmUrologic @nmDisorders
Chapter @nm33: @nmDrugs @nmfor @nmAnemia
Chapter @nm34: @nmDrugs @nmfor @nmDermatologic @nmDisorders
Chapter @nm35: @nmDrugs @nmfor @nmBone @nmDisorders
Chapter @nm36: @nmAnti-inflammatory, @nmAntipyretic, @nmand @nmAnalgesic @nmAgents
Chapter @nm37: @nmPrinciples @nmof @nmAntimicrobial @nmTherapy
Chapter @nm38: @nmCell @nmWall @nmInhibitors
Chapter @nm39: @nmProtein @nmSynthesis @nmInhibitors
Chapter @nm40: @nmQuinolones, @nmFolic @nmAcid @nm Antagonists, @nmand @nmUrinary @nmTract @nmAntiseptics
Chapter @nm41: @nmAntimycobacterial @nmDrugs
Chapter @nm42: @nmAntifungal @nmDrugs
Chapter @nm43: @nmAntiprotozoal @nmDrugs
Chapter @nm44: @nmAnthelmintic @nmDrugs
Chapter @nm45: @nmAntiviral @nmDrugs
Chapter @nm46: @nmAnticancer @nmDrugs
Chapter @nm47: @nmImmunosuppressants
Chapter @nm48: @nmClinical @nmToxicology
, Page @nm1 @nmof @nm507
Pharmacology @nmIllustrated @nmReviews @nm8th @nmEdition @nmWhalen @nmTest
Chapter @nm1:
@nmPharmacokinetics
MULTIPLE @nmCHOICE
1. Which drugs will go through a pharmaceutic phase after it is administered?
a. Intramuscular cephalosporins
b. Intravenous vasopressors
c. Oral analgesics
d. Subcutaneous antiglycemics
ANS: C
When drugs are administered parenterally, there is no pharmaceutic phase, which occurs when a
drug becomes a solution that can cross the biologic membrane.
DIF: COGNITIVE LEVEL: Understanding (Comprehension) REF: dm 3
TOP: NURSING PROCESS: Assessment
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
2. The nurse is preparing to administer an oral medication and wants to ensure a rapid drug
action. Which form of the medication will the nurse administer?
a. Capsule
b. Enteric-coated pill
c. Liquid suspension
d. Tablet
ANS: C
Liquid drugs are already in solution, which is the form necessary for absorption in the GI tract.
The other forms must disintegrate into small particles and then dissolve before being
absorbed.
DIF: COGNITIVE LEVEL: Understanding (Comprehension) REF: dm 3
TOP: NURSING PROCESS: Nursing Intervention
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
, 3. The @nmnurse @nmis @nmteaching @nma @nmpatient @nmwho @nmwill @nmbe @nmdischarged @nmhome @nmwith @nma
prescription @nmfor @nman @nmenteric- @nmcoated @nmtablet. @nmWhich @nmstatement @nmby @nmthe @nmpatient
@nm
@nm indicates @nmunderstanding @nmof @nmthe @nmteaching?
a. I@nmmay@nmcrush @nmthe @nmtablet @nm and @nmput @nmit @nmin @nmapplesauce @nmto @nmimprove @nmabsorption.
b. I@nmshould @nmconsume @nmacidic @nm foods @nmto @nmenhance @nmabsorption @nmof @nmthis @nmmedication.
c. I@nmshould @nmexpect @nm a @nmdelay @nmin @nmonset @nmof @nmthe @nmdrugs @nmeffects @nmafter @nmtaking @nmthe
@nmtablet.
d. I@nmshould @nmtake @nmthis @nmmedication @nmwith @nmhigh-fat @nmfoods @nmto
@nm improve @nmits @nmaction. @nmANS: @nmC
Enteric-coated @nmtablets @nmresist @nmdisintegration @nmin @nmthe @nmacidic @nmenvironment @nmof @nmthe
@nm stomach @nmand @nmdisintegrate @nmwhen @nmthey @nmreach @nmthe @nmsmall @nmintestine. @nmThere @nmis
@nm usually @nmsome @nmdelay @nmin @nmonset @nmof @nmactions @nmafter @nmtaking @nmthese @nmmedications.
@nm Enteric-coated @nmtablets @nmshould @nmnot @nmbe @nmcrushed @nmor @nmchewed, @nmwhich @nmwould @nmalter
@nm the @nmtime @nmand @nmlocation @nmof @nmabsorption. @nmAcidic @nmfoods @nmwill @nmnot @nmenhance @nmthe
@nm absorption @nmof @nmthe @nmmedication. @nmThe @nmpatient @nmshould @nmnot @nmto @nmeat @nmhigh-fat @nmfood
@nm before @nmingesting @nman @nmenteric-coated @nmtablet, @nmbecause @nmhigh-fat @nmfoods @nmdecrease
@nm the @nmabsorption @nmrate.
DIF: @nmCOGNITIVE @nmLEVEL: @nmApplying @nm(Application) @nmREF:
dm @nm3 @nmTOP: @nmNURSING @nmPROCESS: @nmNursing
@nm
@nm Intervention
MSC: @nmNCLEX: @nmPhysiological @nmIntegrity: @nmPharmacological @nmand @nmParenteral @nmTherapies
4. A @nmpatient @nmwho @nmis @nmnewly @nmdiagnosed @nmwith @nmtype @nm1 @nmdiabetes @nmmellitus @nmasks
@nm why @nminsulin @nmmust @nmbe @nmgiven @nmby@nmsubcutaneous @nminjection @nminstead @nmof @nmby@nmmouth.
@nm The @nmnurse @nmwill @nmexplain @nmthat @nmthis @nmis @nmbecause
a. absorption @nmis @nmdiminished @nmby @nmthe @nmfirst-pass @nmeffects @nmin @nmthe @nmliver.
b. absorption @nmis @nmfaster @nmwhen @nminsulin @nmis @nmgiven @nmsubcutaneously.
c. digestive @nmenzymes @nmin @nmthe @nmgastrointestinal @nmtract @nmprevent @nmabsorption.
d. the @nmoral @nmform @nmis @nmless@nmpredictable @nmwith @nmmore
adverse @nmeffects. @nmANS: @nmC
@nm
Insulin, @nmgrowth @nmhormones, @nmand @nmother @nmprotein-based @nmdrugs @nmare @nmdestroyed @nmin @nmthe
small @nmintestine @nmby @nmdigestive @nmenzymes @nmand @nmmust @nmbe @nmgiven @nmparenterally.
@nm
@nm Because @nminsulin @nmis @nmdestroyed @nmby @nmdigestive @nmenzymes, @nmit @nmwould @nmnot @nmmake @nmit
@nm to @nmthe @nmliver @nmfor @nmmetabolism @nmwith @nma @nmfirst-pass @nmeffect. @nmSubcutaneous @nmtissue @nmhas
@nm fewer @nmblood @nmvessels, @nmso @nmabsorption @nmis @nmslower @nmin @nmsuch @nmtissue. @nmInsulin @nmis
@nm given @nmsubcutaneously @nmbecause @nmit @nmis @nmdesirable @nmto @nmhave @nmit @nmabsorb @nmslowly.
DIF: @nmCOGNITIVE @nmLEVEL: @nmUnderstanding @nm(Comprehension)
REF: @nmdm @nm3 @nmTOP: @nmNURSING @nmPROCESS: @nmNursing
@nm
